Current Report Filing (8-k)

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

 

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported):  August 10, 2016

 

The Spectranetics Corporation

(Exact name of registrant as specified in its charter)

 

	Delaware		000-19711		84-0997049
	(State or other jurisdiction		(Commission		(IRS Employer
	of incorporation)		File Number)		Identification No.)

 

9965 Federal Drive

Colorado Springs, Colorado 80921

(Address of principal executive offices) (Zip Code)

Registrant’s telephone number, including area code: [phone]

 

(Former name or former address, if changed since last report.)

  

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

 

o     Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

o     Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

o     Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

o     Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

  

---

Item 8.01      Other Events.

On August 10, 2016, The Spectranetics Corporation issued a press release regarding receipt of CE marking for the AngioSculptX Drug-coated PTCA Scoring Balloon Catheter.  A copy of the press release is filed as Exhibit 99.1 and is incorporated herein by reference.

Item 9.01     Financial Statements and Exhibits.

(d) Exhibits

Exhibit No.	Description
99.1	Press release issued by The Spectranetics Corporation on August 10, 2016

2

---

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

		THE SPECTRANETICS CORPORATION
Date:	August 10, 2016	By:	/s/ Paul Gardon
			Paul Gardon
			Senior Vice President, General Counsel and Corporate Secretary

 

 

 

3

---

 

EXHIBIT INDEX

 

Exhibit No.	Description
99.1	Press release issued by The Spectranetics Corporation on August 10, 2016

4